However, Zepbound (Tirzepatide) generally produces greater average weight loss than Semaglutide due to its dual-hormone action
By taking Mounjaro alongside HRT, women may be able to better counteract some of these menopausal effects: Mounjaros appetite-lowering effect could help overcome increased hunger and food cravings The metabolic benefits of HRT may complement Mounjaros fat-burning effects HRT may help mitigate some of the negative impacts of oestrogen decline on body composition The study published in Menopause found that combining a GLP-1 medication (similar to Mounjaro) and HRT led to an average weight loss of 16%, compared to 12% for those not using HRT
This is one of the most interesting potential applications, though formal head-to-head data in this population is limited
The patients were randomized into four groups: three received different doses of tirzepatide 5, 10, and 15mg per week and the fourth received 1mg semaglutide
Unlike its influence on CAP-induced TRPV1 activation, exendin 939 did not block or potentiate proton-induced channel activity, even at a concentration approximately 30 times greater than its IC 50 value for inhibiting CAP-induced TRPV1 activity, indicating mode-specific inhibition of exendin 939